ArticleTranslational lung cancer research2025

Survival benefits in non-small cell lung cancer during the immune checkpoint inhibitor era: integrating lymph node burden for prognostic precision.

Yuntao Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.